uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of...
Leadership
Matthew Craig Kapusta CPA
CEO & Executive Director
Christian Klemt
CFO, Principal Financial Officer & GM of Amsterdam Site
Jeannette Potts J.D., Ph.D.
Chief Legal & Compliance Officer and Corporate Secretary
Walid Abi-Saab M.D.
Chief Medical Officer
Hugo Katus
Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany
